Groups | Days | Inhibition of platelet aggregation (%) | |||
---|---|---|---|---|---|
AA (500 μg/mL) | ADP (20 μmol/L) | Collagen (10 μg/mL) | Epinephrine (300 μmol/L) | ||
Control | 30 | 69.54 ± 8.12 | 41.54 ± 3.24 | 20.74 ± 1.54 | 14.65 ± 0.88 |
60 | 76.12 ± 7.58 | 41.66 ± 3.68 | 20.65 ± 0.89 | 14.24 ± 0.97 | |
SCD1 | 30 | 65.29 ± 6.21* | 36.66 ± 0.54* | 20.41 ± 0.75 | 13.45 ± 1.24 |
60 | 57.55 ± 7.08* | 37.80 ± 0.87* | 17.54 ± 1.12* | 13.20 ± 1.54* | |
SCD2 | 30 | 60.89 ± 6.29** | 35.37 ± 0.70* | 18.80 ± 0.98 | 13.98 ± 0.95 |
60 | 52.06 ± 5.98** | 33.65 ± 1.21* | 16.99 ± 2.54* | 13.00 ± 0.84* | |
Aspirin | 30 | 43.44 ± 8.45** | 30.45 ± 0.98** | 12.87 ± 1.23** | 12.59 ± 1.05* |
60 | 46.87 ± 8.99** | 26.76 ± 1.25** | 12.33 ± 1.01** | 12.98 ± 0.90* |